For more information, visit: [ Ссылка ] Human pluripotent stem cells (PSCs) hold great potentials in regenerative medicine applications. Yet, GMP-compliant and cost-effective cell manufacturing is still a major challenge for clinical applications across the globe. In many cases, additional sorting of the desired cell populations in a GMP-compliant environment is also required. In this webinar, we will present Miltenyi Biotec’s widely used CliniMACS Prodigy® Platform and MACSQuant® Tyto® Cell Sorter, which provide automated, closed, and GMP-compliant solutions for PSC manufacturing and sorting processes. You will learn:
• How to build customized PSC expansion and differentiation processes in an automated, scalable, and closed manufacturing system.
• How to enrich desired cell populations with a gentle, closed, and GMP-compliant cell sorting technology.
• How our technologies can benefit your PSC manufacturing and sorting processes.
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies enable solutions for cellular research, cell therapy, cell manufacturing, and imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 3,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.
